MedPath

A study to assess result after shoulder surgery

Phase 4
Conditions
Health Condition 1: M999- Biomechanical lesion, unspecified
Registration Number
CTRI/2023/05/053059
Lead Sponsor
Healthium Medtech Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Adult participants between =30 years and = 70 of age at the time of consent

2.Participants with Rotator Cuff Tears requiring primary RCT repair

3.Participants/ Legally Acceptable Representative who are willing to provide written Informed Consent and comply with study procedures

Exclusion Criteria

1.Participants with evidence of osteoarthritis grade 2 and above in the shoulder as per Samilson and Prieto classification

2.Participants with evidence of infection, osteopenia, tumor or necrosis in the shoulder

3.Participants who had undergone previous surgery of the same shoulder

4.Participants having more than grade 3 fatty infiltration and >50% muscle atrophy

5.Participants with uncontrolled diabetes [HbA1c ? 9% (Clinical laboratory reports up to 3 months will be considered valid otherwise participants will undergo blood investigation for HbA1C)

6. Participants with known sensitivity to PEEK/ Titanium/ PLDLA-BTCP material

7.Participants with any condition which makes the subject unsuitable for study participation which as per the investigator would jeopardize the outcome of the trial or participant who, in the judgment of the investigator, will be unlikely to comply with the requirements of this protocol. For ex: Intraoperative diagnosis of severe osteopenia/cyst jeopardizing the stability of the anchor

8.Pregnant and lactating female at the time of screening

9.Participants with known psychiatric disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To assess overall functional outcomes in each cohort of knotless PEEK anchors with titanium tip & knotless PLDLA-BTCP anchors with titanium tip.Timepoint: Time frame Screening or Baseline, month 3, month 6 , month 12, month 18 and month 24
Secondary Outcome Measures
NameTimeMethod
1.To assess the patient reported outcomes in each cohort of knotless PEEK anchors with titanium tip & knotless PLDLA BTCP anchors with titanium tip. <br/ ><br>2.To assess change in quality of life post RCT repair using Sironix all suture anchor in each cohort of knotless PEEK anchors with titanium tip & knotless PLDLA BTCP anchors with titanium tip. <br/ ><br>3.To assess the failure rate in each cohort of knotless PEEK anchors with titanium tip & knotless PLDLA BTCP anchors with titanium tip during RCT repair. <br/ ><br>4.To assess the overall intraoperative handling of knotless PEEK anchors with titanium tip & knotless PLDLA BTCP anchors with titanium tip. <br/ ><br>5.To assess the incidence of residual risks and safety of knotless PEEK anchors with titanium tip & knotless PLDLA BTCP anchors with titanium tip. <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Time frame Screening or Baseline, month 3, month 6 , month 12, month 18 and month 24
© Copyright 2025. All Rights Reserved by MedPath